MedTrace Logo

Infectious Diseases Experts as Part of the Antibiotic Stewardship Team in Primary Care

NCT04848883 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1389

Last updated 2026-03-23

No results posted yet for this study

Summary

A cluster-randomised multicentre blinded clinical trial will be performed in six primary care centres located in the southern metropolitan area of Barcelona (Spain). The objective is to assess whether including experts on infectious diseases (ID) within the antimicrobial stewardship (AMS) team of primary care achieves higher reductions on overall antibiotic consumption and increases the quality of prescription in diagnosed upper respiratory and urinary tract infections.

Centres will be randomly assigned to receive a standard-AMS or an advanced-AMS (intervention). Advanced-AMS includes all standard-AMS strategies plus general practitioner chance to discuss clinical cases by telephone to ID expert on working days (8:00 am to 8:00 pm), and by biweekly meetings.

Conditions

Interventions

BEHAVIORAL

Advanced AMS program

1. \- Telephone acces to infectious disease experts to discuss patients' therpies during working days. 2. \- Biweeckly meetings with infectious diseases experts and antimicrobial stewardship group.

BEHAVIORAL

Standard AMS program

1. \- Educational materials. 2. \- Updated local antibiotic guidelines. 3. \- Promotion of delayed antibiotic prescription. 4. \- Promotion of Streptococcus pyogenes antigen test (Streptotest) if bacterial tonsillitis is suspected. 5. \- Daily report to GP of multiresistant bacteria isolates in urinary samples. 6. \- Quarterly reports to prescribers of AMS outcomes at the centre-level.

Sponsors & Collaborators

  • Institut d'Investigació Biomèdica de Bellvitge

    lead OTHER

Principal Investigators

  • Ariadna Padullés, Pharmacyst · Institut d'Investigació Biomèdica de Bellvitge

  • Evelyn Shaw, Doctor · Institut d'Investigació Biomèdica de Bellvitge

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2023-04-21
Completion
2024-06-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04848883 on ClinicalTrials.gov